The Market Reports

Index

1 Blood Anticoagulant Market Overview
1.1 Product Overview and Scope of Blood Anticoagulant
1.2 Blood Anticoagulant Segment by Type
1.2.1 Global Blood Anticoagulant Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral
1.2.3 Injection
1.3 Blood Anticoagulant Segment by Application
1.3.1 Global Blood Anticoagulant Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Blood Anticoagulant Market Size Estimates and Forecasts
1.4.1 Global Blood Anticoagulant Revenue 2017-2028
1.4.2 Global Blood Anticoagulant Sales 2017-2028
1.4.3 Blood Anticoagulant Market Size by Region: 2017 Versus 2021 Versus 2028
2 Blood Anticoagulant Market Competition by Manufacturers
2.1 Global Blood Anticoagulant Sales Market Share by Manufacturers (2017-2022)
2.2 Global Blood Anticoagulant Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Blood Anticoagulant Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Blood Anticoagulant Manufacturing Sites, Area Served, Product Type
2.5 Blood Anticoagulant Market Competitive Situation and Trends
2.5.1 Blood Anticoagulant Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Blood Anticoagulant Players Market Share by Revenue
2.5.3 Global Blood Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Anticoagulant Retrospective Market Scenario by Region
3.1 Global Blood Anticoagulant Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Blood Anticoagulant Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Blood Anticoagulant Market Facts & Figures by Country
3.3.1 North America Blood Anticoagulant Sales by Country
3.3.2 North America Blood Anticoagulant Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Blood Anticoagulant Market Facts & Figures by Country
3.4.1 Europe Blood Anticoagulant Sales by Country
3.4.2 Europe Blood Anticoagulant Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Blood Anticoagulant Market Facts & Figures by Region
3.5.1 Asia Pacific Blood Anticoagulant Sales by Region
3.5.2 Asia Pacific Blood Anticoagulant Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Blood Anticoagulant Market Facts & Figures by Country
3.6.1 Latin America Blood Anticoagulant Sales by Country
3.6.2 Latin America Blood Anticoagulant Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Blood Anticoagulant Market Facts & Figures by Country
3.7.1 Middle East and Africa Blood Anticoagulant Sales by Country
3.7.2 Middle East and Africa Blood Anticoagulant Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Blood Anticoagulant Historic Market Analysis by Type
4.1 Global Blood Anticoagulant Sales Market Share by Type (2017-2022)
4.2 Global Blood Anticoagulant Revenue Market Share by Type (2017-2022)
4.3 Global Blood Anticoagulant Price by Type (2017-2022)
5 Global Blood Anticoagulant Historic Market Analysis by Application
5.1 Global Blood Anticoagulant Sales Market Share by Application (2017-2022)
5.2 Global Blood Anticoagulant Revenue Market Share by Application (2017-2022)
5.3 Global Blood Anticoagulant Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bayer Blood Anticoagulant Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Boehringer Ingelheim Blood Anticoagulant Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bristol-Myers Squibb Blood Anticoagulant Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Daiichi Sankyo Blood Anticoagulant Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Pfizer Blood Anticoagulant Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Johnson & Johnson Blood Anticoagulant Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Blood Anticoagulant Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.8.4 AstraZeneca Blood Anticoagulant Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eli Lilly Blood Anticoagulant Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Keryx Biopharmaceuticals
6.10.1 Keryx Biopharmaceuticals Corporation Information
6.10.2 Keryx Biopharmaceuticals Description and Business Overview
6.10.3 Keryx Biopharmaceuticals Blood Anticoagulant Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Keryx Biopharmaceuticals Blood Anticoagulant Product Portfolio
6.10.5 Keryx Biopharmaceuticals Recent Developments/Updates
7 Blood Anticoagulant Manufacturing Cost Analysis
7.1 Blood Anticoagulant Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Blood Anticoagulant
7.4 Blood Anticoagulant Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Blood Anticoagulant Distributors List
8.3 Blood Anticoagulant Customers
9 Blood Anticoagulant Market Dynamics
9.1 Blood Anticoagulant Industry Trends
9.2 Blood Anticoagulant Market Drivers
9.3 Blood Anticoagulant Market Challenges
9.4 Blood Anticoagulant Market Restraints
10 Global Market Forecast
10.1 Blood Anticoagulant Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Blood Anticoagulant by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Blood Anticoagulant by Type (2023-2028)
10.2 Blood Anticoagulant Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Blood Anticoagulant by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Blood Anticoagulant by Application (2023-2028)
10.3 Blood Anticoagulant Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Blood Anticoagulant by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Blood Anticoagulant by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Blood Anticoagulant Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Blood Anticoagulant Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Blood Anticoagulant Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Blood Anticoagulant Market Competitive Situation by Manufacturers in 2021
Table 5. Global Blood Anticoagulant Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Blood Anticoagulant Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Blood Anticoagulant Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Blood Anticoagulant Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Blood Anticoagulant Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Blood Anticoagulant Manufacturing Sites and Area Served
Table 11. Manufacturers Blood Anticoagulant Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Blood Anticoagulant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Anticoagulant as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Blood Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 16. Global Blood Anticoagulant Sales Market Share by Region (2017-2022)
Table 17. Global Blood Anticoagulant Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Blood Anticoagulant Revenue Market Share by Region (2017-2022)
Table 19. North America Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 20. North America Blood Anticoagulant Sales Market Share by Country (2017-2022)
Table 21. North America Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Blood Anticoagulant Revenue Market Share by Country (2017-2022)
Table 23. Europe Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 24. Europe Blood Anticoagulant Sales Market Share by Country (2017-2022)
Table 25. Europe Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Blood Anticoagulant Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Blood Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Blood Anticoagulant Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Blood Anticoagulant Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Blood Anticoagulant Revenue Market Share by Region (2017-2022)
Table 31. Latin America Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Blood Anticoagulant Sales Market Share by Country (2017-2022)
Table 33. Latin America Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Blood Anticoagulant Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Blood Anticoagulant Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Blood Anticoagulant Revenue Market Share by Country (2017-2022)
Table 39. Global Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 40. Global Blood Anticoagulant Sales Market Share by Type (2017-2022)
Table 41. Global Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Blood Anticoagulant Revenue Share by Type (2017-2022)
Table 43. Global Blood Anticoagulant Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Blood Anticoagulant Sales (K Units) by Application (2017-2022)
Table 45. Global Blood Anticoagulant Sales Market Share by Application (2017-2022)
Table 46. Global Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Blood Anticoagulant Revenue Share by Application (2017-2022)
Table 48. Global Blood Anticoagulant Price by Application (2017-2022) & (US$/Unit)
Table 49. Bayer Corporation Information
Table 50. Bayer Description and Business Overview
Table 51. Bayer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Bayer Blood Anticoagulant Product
Table 53. Bayer Recent Developments/Updates
Table 54. Boehringer Ingelheim Corporation Information
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Boehringer Ingelheim Blood Anticoagulant Product
Table 58. Boehringer Ingelheim Recent Developments/Updates
Table 59. Bristol-Myers Squibb Corporation Information
Table 60. Bristol-Myers Squibb Description and Business Overview
Table 61. Bristol-Myers Squibb Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Bristol-Myers Squibb Blood Anticoagulant Product
Table 63. Bristol-Myers Squibb Recent Developments/Updates
Table 64. Daiichi Sankyo Corporation Information
Table 65. Daiichi Sankyo Description and Business Overview
Table 66. Daiichi Sankyo Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Daiichi Sankyo Blood Anticoagulant Product
Table 68. Daiichi Sankyo Recent Developments/Updates
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Pfizer Blood Anticoagulant Product
Table 73. Pfizer Recent Developments/Updates
Table 74. Johnson & Johnson Corporation Information
Table 75. Johnson & Johnson Description and Business Overview
Table 76. Johnson & Johnson Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Johnson & Johnson Blood Anticoagulant Product
Table 78. Johnson & Johnson Recent Developments/Updates
Table 79. Sanofi Corporation Information
Table 80. Sanofi Description and Business Overview
Table 81. Sanofi Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Sanofi Blood Anticoagulant Product
Table 83. Sanofi Recent Developments/Updates
Table 84. AstraZeneca Corporation Information
Table 85. AstraZeneca Description and Business Overview
Table 86. AstraZeneca Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. AstraZeneca Blood Anticoagulant Product
Table 88. AstraZeneca Recent Developments/Updates
Table 89. Eli Lilly Corporation Information
Table 90. Eli Lilly Description and Business Overview
Table 91. Eli Lilly Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Eli Lilly Blood Anticoagulant Product
Table 93. Eli Lilly Recent Developments/Updates
Table 94. Keryx Biopharmaceuticals Corporation Information
Table 95. Keryx Biopharmaceuticals Description and Business Overview
Table 96. Keryx Biopharmaceuticals Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Keryx Biopharmaceuticals Blood Anticoagulant Product
Table 98. Keryx Biopharmaceuticals Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Blood Anticoagulant Distributors List
Table 102. Blood Anticoagulant Customers List
Table 103. Blood Anticoagulant Market Trends
Table 104. Blood Anticoagulant Market Drivers
Table 105. Blood Anticoagulant Market Challenges
Table 106. Blood Anticoagulant Market Restraints
Table 107. Global Blood Anticoagulant Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Blood Anticoagulant Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Blood Anticoagulant Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Blood Anticoagulant Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Blood Anticoagulant Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Blood Anticoagulant Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Blood Anticoagulant Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Blood Anticoagulant Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Blood Anticoagulant Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Blood Anticoagulant Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Blood Anticoagulant Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Blood Anticoagulant Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Blood Anticoagulant
Figure 2. Global Blood Anticoagulant Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Blood Anticoagulant Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Blood Anticoagulant Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Blood Anticoagulant Market Size (2017-2028) & (US$ Million)
Figure 11. Global Blood Anticoagulant Sales (2017-2028) & (K Units)
Figure 12. Blood Anticoagulant Sales Share by Manufacturers in 2021
Figure 13. Global Blood Anticoagulant Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Blood Anticoagulant Players: Market Share by Revenue in 2021
Figure 15. Blood Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Blood Anticoagulant Sales Market Share by Region (2017-2022)
Figure 17. Global Blood Anticoagulant Sales Market Share by Region in 2021
Figure 18. Global Blood Anticoagulant Revenue Market Share by Region (2017-2022)
Figure 19. Global Blood Anticoagulant Revenue Market Share by Region in 2021
Figure 20. United States Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Blood Anticoagulant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Blood Anticoagulant by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Blood Anticoagulant
Figure 45. Manufacturing Process Analysis of Blood Anticoagulant
Figure 46. Blood Anticoagulant Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed